ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2020 American Transplant Congress

May 30-June 1, 2020

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z
  • Has Every Possible Life Been Saved?: Rummaging Through the Discard Heap

    A. L. Friedman, E. Marquez

  • HCC Liver Transplantation Waitlist Dropout Rates before and after the Mandated Six-Month Wait-Time

    M. LaVere1, K. Robichaux2, J. Buggs3, E. Rogers3, S. Nyce4, A. Kumar1, J. Sokolich3

  • HCV Viremic Kidneys for Uninfected Recipients with DAA Treatment Offers Sustained Virologic Response

    J. Torabi, A. Montal, M. Ajaimy, L. Lirano, Y. Azzi, C. Pynadath, E. Akalin, J. Melvin, M. Kinkhabwala, S. Greenstein, J. P. Rocca, J. A. Graham

  • HCV-Positive Donors Are Healthier and Inequitably Utilized in the United States

    B. L. Da, T. Kushner, G. Kakked, J. Crismale, G. Ezaz, T. Schiano, B. Saberi

  • Health Mindsets Can Influence Psychosocial Ratings in Pediatric Renal Transplant Patients

    R. Wright, A. Gallo, L. Maestretti, C. Mueller

  • Health Professional Level Barriers to Living Donor Kidney Transplantation: A Mixed Methods Study

    R. Iskander1, M. Cantarovich1, N. Dendukuri1, M. Fortin2, S. Sandal1

  • Health-Related Quality of Life after Anonymous Nondirected Living Liver Donation: A Multi-Center, North American Collaboration

    M. H. Raza1, W. E. Jackson2, A. Dell3, L. Ding4, J. Shapiro3, E. A. Pomfret5, Y. Genyk6, L. Sher6, J. Emamaullee6

  • Healthcare Utilization and Costs of Liver Transplantation for Alcoholic Hepatitis

    G. Im1, A. Vogel1, S. S. Florman2, S. Aqui3, L. Kim-Schluger1, T. Schiano1

  • Heart Transplant Outcomes for Patients with Left Ventricular Assist Devices (LVAD) Before and after the 2018 Revision of the United Network for Organ Sharing (UNOS) Adult Heart Allocation System

    J. Pizula1, K. Yang1, J. Li1, S. Shah1, G. Liu1, A. Lee1, P. Banankhah1, J. Nattiv1, D. Miklin1, P. Genyk1, P. Kingsford1, K. Pandya1, R. Joeseph1, M. Fong1, G. Luanda1, A. Kiankhooy1, S. Hashmi1, S. Nuno1, A. Wolfson2, A. Salimbangon3, R. Chand4, D. Vucicevic5, L. Corey6, E. Depasquale1, A. Vaidya1

  • Heart Transplant Outcomes in Adults with Peripartum Cardiomyopathy

    P. Genyk, K. Yang, G. Liu, J. Nattiv, P. Banankhah, P. Kingsford, J. Li, S. Nuno, K. Pandya, A. Vaidya, E. DePasquale

  • Heart Transplant Outcomes in Patients Who Receive Hepatitis B Virus-Positive Donor Hearts: A UNOS Registry Analysis

    P. Genyk1, K. Yang2, R. Chand3, E. Depasquale1

  • Heart Transplantation Outcomes in Multiorgan Transplants

    P. Kingsford1, J. P. Li1, C. J. Lum2, A. Salimbangon3, G. Liu1, A. M. Wolfson4, R. R. Chand5, P. Banankhah1, P. A. Genyk1, D. Vucicevic6, K. Pandya1, J. Rahman1, M. Fong1, L. Grazette1, A. Kiankhooy1, J. Nattiv1, S. Hashmi1, S. B. Nuno1, J. Pizula1, D. J. Miklin1, A. E. Lee1, K. Yang1, S. Shah1, A. S. Vaidya1, E. C. DePasquale1

  • Heart Transplantation Outcomes in Patients with Marfan Syndrome: A UNOS Registry Analysis

    P. Genyk1, K. Yang1, J. Pizula1, A. Lee1, D. Miklin1, S. Shah1, S. Nuno1, S. Hashmi1, J. Nattiv1, A. Kiankhooy1, L. Grazette1, M. Fong1, J. Rahman1, K. Pandya1, A. Vaidya1, D. Vucicevic2, J. Li1, P. Kingsford1, P. Banankhah1, A. Wolfson3, G. Liu1, R. Chand4, E. Depasquale1

  • HELLP Me! My Liver Ruptured and Nobody Can Give Me Platelets: A Case Study of Liver Transplantation for Liver Rupture from HELLP Syndrome

    R. Cooke, M. Williams, M. A. Adams

  • Hematopoietic Cell Kinase Promotes Kidney Fibrosis Through Autophagy Pathway

    C. Wei, L. Mou, K. Banu, M. Menon, W. Zhang, C. He, B. Murphy

  • Hematopoietic Cell Transplantation and Solid Organ Transplantation: Outcomes of Sequential Transplantation in the United States

    M. Gupta1, M. Levine2, D. Porter2, R. Brazauskas3, S. Bo-Subait4, R. Phelan3, M. Battiwalla5, D. Buchbinder6, B. Hamilton7, B. Shaw3, P. Abt2

  • Hemodialysis (HD) Treatment Associates with Increased Risk of Delayed Graft Function (DGF) after Renal Transplantation (RT) and Augmented Cd4 and Cd8 T Cell Proliferation Compared to Peritoneal Dialysis (PD)

    A. Angeletti1, C. Donadei1, G. Donati1, G. Di Certo1, D. Conte1, L. Gasperoni1, E. Pelizzaro1, C. Guglielmo1, G. Comai1, P. Cravedi2, G. La Manna1

  • Hepatic Artery Reconstruction in Living Donor Liver Transplantation Using Surgical Loupes: Achieving Low Rate of Hepatic Arterial Thrombosis in Consecutive 1000 Recipients- Tips and Tricks to Overcome the Poor Hepatic Arterial Flow

    A. Thorat, L. Jeng, S. Hsu, P. Li, H. Yang, T. Chen, K. Poon

  • Hepatic Artery Thrombosis in the Modern Era of Increased Utilization of Livers from Older Donors

    A. Kernodle, M. Krach, P. Chiang, D. Segev, A. Massie, J. Garonzik-Wang

  • Hepatic Microenvironment: Molecular and Chemical Changes Associated with Preconditioning Maneuvers

    I. Lies, C. Watkins, M. Em, J. D. Eason, C. Eynard, T. Rousselle, V. R. Mas, D. Maluf

  • Hepaticojejunostomy versus Duct to Duct Anastomosis in Liver Transplantation: An Old Question Revisited

    A. M. Elsabbagh, M. T. Shamaa, A. Al-Kurd, F. Tinney, T. Ivanics, A. Mohamed, K. Delvecchio, S. Yeddula, M. Rizzari, K. Collins, A. Yoshida, M. Abouljoud, S. Nagai

  • Hepatitis B Virus Prophylaxis and Treatment among Hematopoietic Stem Cell Transplant Recipients: Impact on Engraftment and Outcomes

    B. Buzo1, J. Fernandes Ramos2, R. Marques Rossetti3, N. Salles4, A. Mendrone-Junior4, V. Rocha3, A. de Seixas Santos Nastri5

  • Hepatitis C and Racial Disparity in Liver Transplant Waitlist Additions: Separate Not Equal

    C. Wang1, J. Buggs1, E. Rogers1, A. Kumar2, N. Kemmer3

  • Hepatitis C Antibody Seroconversion after Transplantation of Kidneys from Hepatitis C Infected Donors to Hepatitis C Negative Recipients

    U. A. Agbim1, O. Cseprekal2, M. Yazawa1, M. Talwar1, V. Balaraman1, A. Bhalla1, P. S. Podila3, B. Maliakkal1, S. Nair1, J. D. Eason1, M. Z. Molnar1

  • Hepatitis C Antibody Seroconversion in Kidney Transplant Patients from HCV Antibody Positive/NAT Negative Donors Does Not Deteriorate Renal Allograft Outcome

    R. Rattanavich, M. De Vera, T. Hoang, R. Villicana

  • Hepatitis C-Infected Donors and Hepatitis C-Infected Recipients: Analysis of Renal Transplant Outcomes

    H. Crossman1, M. Tavakol2, C. Freise2, P. Chin-Hong3

  • Hepatocellular Carcinoma Locoregional Therapy: A Comparison of Radiologic Treatment Response and Post-Transplant Pathology

    A. J. Hargrove1, T. Donovan2, K. Fisher3, M. Goodenberger4, A. Langnas1, S. Merani1

  • Hepatocellular Carcinoma Recurrence after Severe Acute Cellular Rejection

    M. Najjar1, O. Perez1, K. Bruestle1, A. Qian1, P. Jiang1, A. Srivastava1, Y. Saenger1, E. Verna1, E. Zheng1, A. Mathur1, A. Griesemer1, K. Halazun2, B. Samstein2, T. Kato1, J. Emond1

  • Hepatocyte Growth Factor (HGF) Prevents the Apoptotic and Anti-Angiogenic Effect of Hypercholesterolemia on Hepatocytes in Liver Allografts

    H. B. Ozdemir1, G. Ozgun1, A. Yucel Polat1, N. Haberal1, G. Moray2, M. Haberal2

  • Hepatologist and Surgeon Experiences Counseling Liver Transplant Candidates for an Organ Offer Decision

    C. Schaffhausen1, M. Bruin2, S. Chu3, S. Chinnakotla4, J. R. Lake5, A. K. Israni6

  • Hif-1a Expression Influences Recipient Clinical Outcomes in Liver Transplant Patients

    K. Kadono, T. Ito, H. Kojima, K. Nakamura, H. Hirao, S. Kageyama, K. J. Dery, A. Murray, R. W. Busutill, F. Kaldas, J. W. Kupiec-Weglinski

  • High Estimated Glomerular Filtration Rate at the First Year after Kidney Transplantation is Associated with Worse Long-Term Graft Survival in Kidney Recipient

    H. Choi1, K. Huh2, M. Kim2, S. Kim2, Y. Kim2, B. Kim1

  • High Frequencies of Donor-Derived Memory T and NK Cells in the Blood of Lung Transplant Recipients May Contribute to Protection from Chronic Lung Allograft Dysfunction

    R. Bellmàs Sanz1, A. Hitz1, B. Wiegmann2, K. Bläsing1, F. Ius2, W. Sommer2, J. Kühne1, L. Horn1, A. Knöfel2, I. Tudorache2, A. Haverich2, D. Jonigk3, G. Warnecke2, C. Falk1

  • High Health Literacy is Associated with Decreased Likelihood of Waitlist Mortality for Some Solid Organ Transplant Candidates

    L. Dageforde1, S. Rega2, I. Feurer3

  • High Intra-Patient Variability of Tacrolimus in Pediatric and Adolescent Renal Transplant Recipients is Associated with Worse Graft Outcomes

    K. Piburn1, L. Maestretti2, R. Shetty2, M. V. Patton2, A. McGrath2, W. Concepcion1, A. Chaudhuri1, P. C. Grimm1, V. K. Sigurjonsdottir3

  • High Laminin Alpha 5 Expression is Observed in the Pancreas of Chronic Pancreatitis Patients and Correlates with Poor Autologous Islet Transplant Outcome

    Y. Liu, K. Kumano, S. Vasu, C. M. Darden, M. Lawrence, B. Naziruddin

  • High PRA Increases Rejection but Does Not Worsen Renal Function in the First Year Post Kidney Transplant with Alemtuzumab Induction

    B. Wise, A. Freeman, M. Janusek, S. Anders, L. Hutchinson, U. Kaszubski, D. Marroquin, D. Martin, H. Bohorquez

  • High Rate of Positive Cultures from Deceased Donors, A Review of 500 Deceased Donors and More Than 700 Recipients from a Single Center in Saudi Arabia

    R. S. Almaghrabi1, R. Alameer1, O. Zeitoni2, M. Ahmed3, I. Nizami3, J. Alburaiki4, T. Aljurf1, R. Alyamany1, A. Abed2, D. Broering3

  • High Volume, Highly Efficient, Outcome- Centric KPD Program: A Single Center Experience with Direct Exchange Based Strategies

    K. Al Meshari, D. Broering, I. Alahmadi, S. Raza, T. Ali, A. Alabbassi, H. Alahdal, F. Alzayer

  • High-Activity Classical and Alternative Complement Pathway Genotypes – Association with Donor-Specific Antibody-Triggered Injury and Renal Allograft Survival

    R. Reindl-Schwaighofer1, B. Mezö2, F. Eskandary1, A. Heinzel1, M. Wahrmann1, K. Doberer1, A. Heilos3, G. Bond1, J. Kläger4, N. Kozakowski4, H. Haslacher5, R. Oberbauer1, O. Viklický6, P. Hruba6, P. F. Halloran7, K. Rusai3, Z. Prohászka8, G. A. Böhmig1

  • High-Risk Antibodies Pre-Transplant Impacts Outcome after Heart Transplantation

    J. A. Kobashigawa, M. Kittleson, J. Patel, D. Chang, E. Kransdorf, D. Geft, K. Nishihara, A. Shen, L. Czer, F. Esmailian

  • Higher Body Mass Index Before Living Kidney Donation Can Increase Wound Infection after Hand-Assisted Laparoscopic Living Donor Nephrectomies

    X. Benavides, M. Merzkani, R. T. Rogers, E. K. Tan, S. Thirunavukkarasu, B. H. Smith, A. D. Rule, M. Prieto, J. K. Heimbach, T. Taner, G. K. Chow, P. G. Dean, M. D. Stegall

  • Higher Probability of Living Donor Liver Transplantation is Associated with DSAs Having a Higher Median Meld at Transplant

    D. Haakinson1, S. Noreen2, D. Stewart2, R. Batra1, G. Gan1, Y. Deng1, S. Kulkarni1

  • Higher State-Level Demand for Renal Transplantation is Associated with Lower Deceased Donor Kidney Transplantation Rate

    A. C. Kale, H. Qu, P. MacLennan, R. Reed, D. Anderson, M. N. Mustian, B. Orandi, B. Shelton, V. Kumar, M. J. Hanaway, J. E. Locke

  • Highly Effective Short Course Therapy to Prevent Infection after Transplantation from HCV-Infected Organ Donors to Uninfected Recipients across Multiple Organ Types

    A. Humar1, M. Cypel1, D. Kumar1, H. Dahari2, R. Vanin Pinto Ribeiro1, N. Marks1, N. Kamkar1, I. Bahinskaya1, F. Onofrio3, M. A. Zahoor3, O. Cerrochi3, K. Tinckam1, S. J. Kim1, T. W. Reichman1, M. McDonald1, T. K. Waddell1, G. Sapisochin1, M. Selzner1, S. Keshavjee1, H. L. Janssen3, B. E. Hansen3, L. Singer1, J. Feld3

  • History of Coronary Artery Disease Predicts Inferior Survival in Liver Transplant Recipients of Advanced Age in a Large Multicenter U.S. Cohort

    M. German1, A. Hristov1, A. Lee1, F. Osman1, A. Kwong2, D. Devuni3, C. Wang4, J. Boike5, J. Jo5, L. VanWagner5, M. Serper6, R. Sharma7, E. Verna7, J. Shor3, A. Koteish8, G. Sehmbey9, A. Seetharam9, N. John2, Y. Patel10, M. Kappus10, T. Couri11, S. Paul11, R. Salgia12, Q. Nhu13, C. Frenette13, J. Lai4, A. Goel2, E. Spengler1

  • HIV+ Living Kidney Donors in the United States: Cases and a Clinical Paradigm

    D. Segev1, C. Wolfe2, D. Brown3, D. Fine3, K. Neumann4, N. Martinez5, D. Ostrander3, F. Al Ammary3, A. Tobian3, A. W. Baker6, C. Durand3

  • HLA Cross-Dressing of Dendritic Cells by Maternal Exosomes is Associated with PD-L1 Expression in Newborns

    D. Lema1, S. Kanaan2, J. Nelson2, W. Burlingham1

  • HLA Cw12 in Kidney Transplant Recipients is a Novel Risk Factor for the Development of Post-Transplantation Diabetes: A Single-Centre Retrospective Study

    N. Phagura1, A. Culliford2, F. Evison3, S. Gallier3, J. Nath2, D. Briggs4, A. Sharif2

  • HLA Diversity Affects Epitope Mismatch Cutoffs Utilized to Predict De Novo DSA Development and Graft Rejection in Renal Transplant Patients

    A. Ram1, S. Dhingra2, H. Quach1, P. T. Jindra1

  • HLA Mismatch Immunogenicity: Are We Predicating Mismatches That Induce De Novo DSA Development or That Do Not?

    V. Jucaud1, L. Rebellato2, K. Briley2, C. Haisch2, S. Kendrick3, H. Jones3, K. Mclawhorn3, D. Leeser2, M. Everly1

  • HLA Molecular Mismatch Analysis in Recipients of Kidney Plus Hematopoietic Stem/Facilitating Cell Transplant Tolerance Induction Protocol

    C. Garcia-Sanchez1, V. Kosmoliaptsis2, H. Copley2, J. Leventhal1, S. Ildstad3

  • HLA Molecular Mismatch is an Independent Correlate of T-Cell Mediated Rejection and Potential Prognostic Biomarker in Renal Transplantation

    C. Wiebe1, D. Pochinco2, I. W. Gibson3, J. Ho1, P. Birk4, A. Goldberg4, M. Karpinski5, J. Shaw5, R. N. David5, P. W. Nickerson1

  • HLA Specific Antibody Levels after EDTA Treatment in CDC Crossmatch Positive and Negative Sera with Known Donor-Specific Antibodies

    J. Lauronen1, T. Jaatinen1, J. Holgersson2, C. Naper3, J. Peräsaari1

  • HLA-Antibody Develops Preferentially in Healthy Subjects with a T-bethiB Cell Response to Vaccine

    A. Nellore, G. R. Martens, J. T. Killian, J. Houp, E. Zumaquero, B. Mousseau, J. Bradley, F. Zhou, P. A. Goepfert, F. E. Lund

  • HLA-DQ Plays an Important Role in Graft Survival in African American Transplant Recipients

    L. M. Rebellato1, W. Irish2, D. Leeser2, J. Tuttle2, C. E. Haisch2

  • HLA-DR/DQ Molecular Mismatch Dictates Early Risk of De Novo Donor-Specific Antibody Development and Offers a Personalized Approach to Immunosuppression Management in Kidney Transplantation

    S. Davis1, C. Wiebe2, K. Campbell1, C. Anobile3, M. Aubrey3, A. Wiseman1, E. Pomfret1, P. Nickerson2, J. Cooper1

  • HMGB1 Antagonizes the Immunosuppressive Effect of MSCs in AKI

    S. Cai1, S. Wang2, W. Zhang2, A. Chandraker1, C. Yang2, T. Zhu2

  • How Advantaged are Kidney-Pancreas Candidates for Deceased-Donor Kidney Transplants, and is This Appropriate?

    A. Massie, M. Nguyen, R. Wesson, M. Henderson, N. Desai, D. Segev

  • How Prepared are Potential Donors to Donate?: Racial/Ethnic Differences in Potential Kidney Donors’ Knowledge and Education Before Starting Evaluation

    A. Waterman1, O. N. Ranasinghe1, Y. Cui2, J. L. Beaumont2, D. Adey3, U. Reddy4, B. Campbell5, F. L. Weng6

  • Human Antigen R (HuR): A New Regulator of Heme Oxygenase-1 Cytoprotection in Mouse and Human Liver Transplantation

    K. J. Dery1, K. Nakamura2, K. Kadono1, H. Hirao1, S. Kageyama1, T. Ito1, H. Kojima1, F. Kaldas1, R. W. Busuttil1, J. W. Kupiec-Weglinski1

  • Human Live Donor Liver Transplantation is Associated with Pd-l1 Expression on Donor-Exosome-Acquiring Host Dendritic Cells

    D. Lema, E. Jankowska-Gan, D. Al-Adra, W. Burlingham

  • Human Organ Culture: A Novel Method for Evaluation of Reperfusion Injury in Human Kidney

    J. T. Langford1, C. Edwards1, J. DiRito2, M. Harris1, S. A. Hosgood3, M. L. Nicholson3, J. S. Pober4, D. Haakinson1, G. T. Tietjen1

  • Human Thrombomodulin Gene Expression on Genetically Modified Donor Pig Hearts is Correlated with Long Term Xenograft Survival

    A. K. Singh, C. Goerlich, G. Braileanu, A. Hersfield, T. Zhang, I. Tatarov, B. Lewis, F. Sentz, D. Ayares, K. Horvath, D. Kaczorowski, B. Griffith, M. M. Mohiuddin

  • Human, Monkey Transplant Tolerance and IL35 “Exokine

    W. J. Burlingham1, E. Jankowska-Gan2, D. Lema2, J. H. Fechner2, J. A. Sullivan2, D. B. Kaufman2

  • Humanized Mouse Reveals the Cytoprotective Function of Hepatocyte RXFP1 in Liver Transplant Recipients

    H. Kojima1, S. Kageyama1, K. Kadono1, H. Hirao1, K. J. Dery1, T. Ito1, G. Sugahara2, Y. Ishida2, T. Saito2, F. M. Kaldas1, R. W. Busuttil1, J. W. Kupiec-Weglinski1

  • Humoral Sensitization Overrides Pregnancy-Induced T Cell Transplantation Tolerance

    D. Tran1, A. Suah1, S. Khiew1, J. Young1, M. Andrade1, J. Pollard1, Q. Wang1, D. Yin1, G. Chalasani2, M. Alegre1, A. Chong1

  • Hydroxychloroquine is Associated with Better Patient and Graft Survival in Kidney Transplant Patients with Lupus Nephritis as Cause of ESRD

    T. Singh1, S. Garg2, S. Panzer1

  • Hyperammonemia Syndrome in a Kidney Transplant Recipient Caused by Quinolone-Resistant Ureaplasma Infection

    A. B. Higgins1, R. Rogers2, A. J. Osband3, R. Gohh4, P. Morrissey3, A. Seo1, B. Chen1, D. Crabb5, S. Leal5, K. Waites5, D. Farmakiotis2, G. J. Nau2

  • Hyperlipidemia Prevalence and Treatment in Pediatric Kidney Transplantation

    A. Serluco1, A. Berganini1, R. Liverman1, R. George2, R. Garro2, P. Winterberg2

  • Hypernatremia Predicts Waitlist Death and Deterioration, but Not Post-Transplant Outcomes in Pediatric Liver Transplant Candidates

    L. Thalji1, N. Thalji2, S. Ibrahim3, J. Heimbach2, P. Kamath4, D. Haile1, D. Kor1

  • Hyperspectral Imaging of Human Kidney Allografts

    R. Sucher1, H. Köhler2, A. Lederer1, H. M. Hau1, I. Gockel1, D. Seehofer1

  • Hypothermia Attenuates Renal Fibrosis after Renal Ischemia Reperfusion in Mice

    D. Choi1, D. Kim2, E. Kim2, J. Jeong2, J. Kim1, Y. Ham1, Y. Chang3, K. Na1, K. Lee1

  • Hypothermic Machine Perfusion Can Improve Hypoxia Tolerance in Human Discarded Liver

    T. Ito, K. Kadono, H. Kojima, S. Kageyama, H. HIrao, K. Nakamura, K. J. Dery, A. E. Murray, J. Aziz, R. W. Busuttil, J. Kupiec-Weglinski, F. M. Kaldas

  • Hypothermic Oxygenated Machine Perfusion vs Static Cold Storage: Preliminary Clinical Experience from a Prospective, Multi-Center Randomized Controlled Trial

    G. G. Panayotova1, R. Quillin III2, F. Paterno1, K. Lunsford1, M. A. McCarty1, A. Bailey2, G. Dikdan1, J. Rosado1, S. Shah2, J. V. Guarrera1

Jump to:  View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences